Prevalence of Macroprolactin in Hyperprolactinemic patients receiving Anti-psychotics
View ORCID ProfileLoai Ali Al Mortada Al Wasify, Shaikha Said Al Maamary, Mohammed Nasser Rashid Al Tobi
doi: https://doi.org/10.1101/2021.05.11.21256928
Loai Ali Al Mortada Al Wasify
1MOH - Oman - Al Masarra Hospital;
Shaikha Said Al Maamary
2MOH - Al Masarra Hospital - Oman;
Mohammed Nasser Rashid Al Tobi
3Sultan Qaboos University - College of Medicine
Posted May 11, 2021.
Prevalence of Macroprolactin in Hyperprolactinemic patients receiving Anti-psychotics
Loai Ali Al Mortada Al Wasify, Shaikha Said Al Maamary, Mohammed Nasser Rashid Al Tobi
medRxiv 2021.05.11.21256928; doi: https://doi.org/10.1101/2021.05.11.21256928
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (204)
- Cardiovascular Medicine (2961)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12768)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4604)
- Geriatric Medicine (420)
- Health Economics (731)
- Health Informatics (2935)
- Health Policy (1069)
- Hematology (390)
- HIV/AIDS (927)
- Medical Education (429)
- Medical Ethics (116)
- Nephrology (472)
- Neurology (4384)
- Nursing (237)
- Nutrition (641)
- Oncology (2282)
- Ophthalmology (648)
- Orthopedics (258)
- Otolaryngology (326)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (499)
- Public and Global Health (6969)
- Radiology and Imaging (1537)
- Respiratory Medicine (917)
- Rheumatology (442)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)